Helius Medical Technologies is trading 6.99% up at $1.99, based on live price context; the catalyst remains unclear.
- No clear company-specific announcement dated August 21, 2026 was identified in available coverage.
- The most recent material event was the August 14 second-quarter report, which described $2.5 million in revenue and a Tokyo validator launch, but does not directly explain today’s move.
- Healthcare is declining, while broader indexes are mixed-to-positive and cryptocurrency markets remain strong.